Novartis Pharmaceuticals brings innovative medicines to market to enhance health outcomes for patients and offer solutions to the healthcare providers who treat them.
A Cell Processing Specialist at work in Novartis’ new cell and gene production facility in Stein, Switzerland.

AveXis is now Novartis Gene Therapies

Novartis Gene Therapies is dedicated to developing and commercializing gene therapies for patients and families devastated by rare and life-threatening neurological genetic diseases.

Learn More

Novartis Global Product Portfolio and Clinical Pipeline


Countries in which products are available


New molecular entities in our global clinical pipeline


Therapeutic areas

At Novartis, we invest in the most promising frontiers of science, the most exciting innovations in the business of medicine, and the most significant healthcare needs. Through our focused portfolio, we’re reimagining drug development across five therapeutic areas. 

Cardiovascular, Renal and Metabolism

Cardiovascular (CV), renal and metabolic diseases are a global health crisis. Billions of people are affected physically, emotionally and financially. These chronic, complex, debilitating and often hereditary diseases are frequently inter-related. Yet there continues to be healthcare system and treatment barriers, and a lack of transformative medicines. 

Thanks to a combination of our legacy, global footprint and leading science, Novartis is uniquely positioned to help change this landscape. Our efforts include use of early interventions and development of pioneering treatments that address the spectrum of CRM diseases, from prevention to management, as well as the creation of innovative access models. Our goal is to reduce and ultimately stop premature death and disability from CV disease.

Immunology and Dermatology 

Novartis is a global leader in immunology and dermatology. We are transforming the lives of people living with immunologic diseases, focusing on specialty dermatology, rheumatology, autoinflammatory, transplant, and specialty liver diseases where there remain high unmet medical needs.


Novartis is reimagining the treatment and prevention of visual impairment and blindness. We aim to develop life-changing pharmaceuticals and transformative technologies for diseases and conditions from front to back of the eye.


Novartis has been tackling neurological conditions for more than 80 years. Above all, partnering with patients, healthcare professionals and healthcare systems to deliver life-changing solutions and treatments is at the core of what we do. Together, we can innovate to reimagine neuroscience and improve people’s lives


At Novartis, our focus is on improving the lives of the hundreds of millions of people living with respiratory diseases, including chronic obstructive pulmonary disease (COPD) and severe allergic asthma.



Recent Jobs in Pharmaceuticals

When science and passion connect, innovation happens. Join us.

When science and passion connect, innovation happens. Join us.

Sales, Mexico, SANDOZ
Marketing, Italy, PHARMA
Audit & Finance, France, SANDOZ
Germany, Novartis Technical Operations